This is not the most recent version of the article. View current version (19 DEC 2013)

Intervention Review

Zonisamide add-on for drug-resistant partial epilepsy

  1. David W Chadwick*,
  2. Anthony G Marson

Editorial Group: Cochrane Epilepsy Group

Published Online: 19 OCT 2005

Assessed as up-to-date: 14 FEB 2008

DOI: 10.1002/14651858.CD001416.pub2


How to Cite

Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001416. DOI: 10.1002/14651858.CD001416.pub2.

Author Information

  1. Clinical Sciences Centre for Research & Education, University Department of Neurological Science, Liverpool, Merseyside, UK

*David W Chadwick, University Department of Neurological Science, Clinical Sciences Centre for Research & Education, Lower Lane, Fazakerley, Liverpool, Merseyside, L9 7LJ, UK. r.jowett@liv.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 OCT 2005

SEARCH

This is not the most recent version of the article. View current version (19 DEC 2013)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.